Features and Benefits of using the Bowman Perfusion Monitor in Neurocritical Care and Neurosurgery
Many neurocritical care patients needlessly suffer severe complications or death resulting from undetected ischemia. There is a need to continuously measure cerebral blood flow in absolute units, at the bedside. The Bowman Perfusion Monitor is the only medical device that meets this need.
This webinar will address:
This webinar is aimed at clinicians who manage and care for patients with injuries resulting in compromised blood flow and would like to learn about real-time, absolute measurements of cerebral blood flow.
- The clinical utility of monitoring cerebral blood flow (CBF) and its use in clinical decision making:
- Real-time detection of critical levels of flow using thresholds
- Assess state of cerebral autoregulation
- Differentiate vasospasam and hyperemia during elevated TCD measurements
- Assess the effects of interventions on CBF
- Provides information when used may reduce risk of neurological complications
- CBF as a predictor of patient outcomes
- Role of CBF monitoring in Multi-Modal Monitoring
- The features and benefits of using the Bowman Perfusion Monitor
- Neurocritical care applications: SAH, TBI, ICH
- Neurosurgical applications: Aneurysm repair(TAO), EC/IC Bypass, MoyaMoya surgery
- Potential Economic savings by incorporating the BPM in your clinical practice
H. Frederick Bowman, Ph.D.,
President, CEO & Chairman
H.Frederick Bowman, Ph.D. is the inventor of the Company’s technology and the founder of Hemedex. 40+ years leadership experience in the development of thermal diffusion technologies and commercialization of medical devices. 25 yrs ME/BME faculty member, 2 yr program director NSF and first employee of the Harvard-MIT Division of Health Sciences and Technology. 20 patents, 120 papers/abstracts.
Scott D. Greenwald, Ph.D.,
Vice President of Technology
Scott Greenwald, Ph.D. VP of Technology. 20+ yrs leading research in the development of patient monitoring technologies at Hemedex, and formerly Covidien and Aspect Medical Systems, Inc. He is a co-inventor of 3 novel patient monitoring technologies (BIS, CVI, ATR), co-author of 8 US Patents, and co-author of 100+ publications. Trained at Duke, MIT and Harvard.